GlassScriptPhysician profile
Joseph H Chammas
NPI 1902888522
$935.01
in general payments reported to CMS, 2019-2025
11 companies · $209 in 2025
The $209 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234 · 2023: $113 · 2024: $379 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $520 · Long Term Medical Supply Or Device Loan: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.61 |
| Long Term Medical Supply Or Device Loan | $181.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $237.08 | 2024 | Ellipsys Vascular Access System |
| Integra Lifesciences Corporation | $209.24 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $161.47 | 2023-2024 | Collagenase Santyl, Regranex |
| Janssen Pharmaceuticals, INC | $125.00 | 2019 | |
| Biom'Up Sa | $73.14 | 2019 | |
| Aroa Biosurgery Incorporated | $34.25 | 2023 | |
| Polynovo North America LLC | $29.01 | 2024 | Novosorb Btm |
| Ethicon US, LLC | $18.18 | 2019 | |
| Chiesi USA, INC. | $17.92 | 2019 | |
| Artivion, INC. | $16.01 | 2024 | Photofix Decellularized Bovine Pericardium, Vascular |
| Boston Scientific Corporation | $13.71 | 2023 | Express Ld Iliac / Biliary |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Chammas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.